Cliniphar Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024
Period Ending	Jan '26 Jan 16, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Market Capitalization	1,450	1,450	-	-
Enterprise Value	1,375	1,375	-	-
Last Close Price	1450.00	1450.00	-	-
PE Ratio	9.01	9.01	-	-
PS Ratio	0.39	0.39	-	-
PB Ratio	1.17	1.17	-	-
P/TBV Ratio	1.23	1.23	-	-
P/FCF Ratio	5.39	5.39	-	-
P/OCF Ratio	5.20	5.20	-	-
EV/Sales Ratio	0.37	0.37	-	-
EV/EBITDA Ratio	8.28	8.28	-	-
EV/EBIT Ratio	10.26	10.26	-	-
EV/FCF Ratio	5.11	5.11	-	-
Debt / Equity Ratio	0.83	0.83	1.39	1.41
Debt / EBITDA Ratio	6.23	6.23	-	-
Debt / FCF Ratio	3.85	3.85	-	-
Net Debt / Equity Ratio	-0.33	-0.33	0.27	0.03
Net Debt / EBITDA Ratio	-2.44	-2.44	-	-
Net Debt / FCF Ratio	-1.51	-1.51	-	-
Asset Turnover	1.41	1.41	1.45	-
Inventory Turnover	10.60	10.60	12.27	-
Quick Ratio	1.74	1.74	2.14	4.76
Current Ratio	2.15	2.15	2.73	5.69
Return on Equity (ROE)	14.25%	14.25%	20.17%	-
Return on Assets (ROA)	3.18%	3.18%	3.52%	-
Return on Invested Capital (ROIC)	12.59%	12.59%	12.20%	17.95%
Return on Capital Employed (ROCE)	7.90%	7.90%	6.70%	8.00%
Earnings Yield	11.10%	11.10%	-	-
FCF Yield	18.55%	18.55%	-	-